Volume 10, Issue 2 (2019, Volume 10, Number 2 2019)
jdc 2019, 10(2): 125-127 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Fattahi A, Zarei Mahmoudabadi A. Letter to editor: Recent advances in management of mycetoma in Iran. jdc 2019; 10 (2) :125-127
URL: http://jdc.tums.ac.ir/article-1-5395-en.html
URL: http://jdc.tums.ac.ir/article-1-5395-en.html
1- Center for Research and Training in Skin Disease and Leprosy, Tehran University of Medical Sciences, Tehran, Iran , afattahi@sina.tums.ac.ir
2- Department of Medical Mycology, Faculty of Medicine, Infectious and Tropical Diseases Research Centre, Jundishapur University of Medical Sciences, Ahvaz, Iran
2- Department of Medical Mycology, Faculty of Medicine, Infectious and Tropical Diseases Research Centre, Jundishapur University of Medical Sciences, Ahvaz, Iran
Abstract: (2297 Views)
Mycetoma usually involves the skin, the subcutaneous tissues and deep structures such as the muscle and bone, but infection can also spread to more distant sites through the blood and lymph. If left untreated, the disease leads to deformity and loss of function, which may be fatal. The disease has a severe medical and socioeconomic impact on individuals, communities and health authorities. Elaborating a public health strategy for the prevention and control of mycetoma will require collection of epidemiological data on its burden as well as precise diagnosis and early treatment strategies.
Type of Study: case report |
Subject:
Special
Received: 2019/09/24 | Accepted: 2019/09/24 | Published: 2019/09/24
Received: 2019/09/24 | Accepted: 2019/09/24 | Published: 2019/09/24
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
